Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03840733
Other study ID # 18-1319
Secondary ID K01HL145023
Status Enrolling by invitation
Phase
First received
Last updated
Start date January 7, 2019
Est. completion date January 2024

Study information

Verified date August 2023
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This study is designed as an observational trial. The objective of this study is to follow-up with participants 3 years after completion of an 18-month comprehensive behavioral weight loss intervention. Outcomes of interest include change in body weight, body composition, physical activity, energy intake, and sleep. In addition, investigators will explore the associations between current physical activity, sleep, and energy intake patterns and body weight regulation.


Description:

A total of 170 participants were initially enrolled in the comprehensive behavioral weight loss intervention.In this study, investigators will conduct a follow-up visit 3 years after the completion of the intervention. Only participants who completed the behavioral weight loss intervention will be enrolled in this study. Participants will undergo testing of body weight, body composition, physical activity patterns, energy intake patterns, sleep patterns, resting metabolic rate, and total daily energy expenditure.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 60
Est. completion date January 2024
Est. primary completion date January 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356) - Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial) - Capable and willing to give informed consent - Possess a smartphone to install and utilize the meal timing application - Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days - Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes Exclusion Criteria: - Being considered unsafe to participate as determined by the study physician (Dr. Catennaci) - New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases) - Women who became pregnant after completing the Parent Trial - Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep

Study Design


Locations

Country Name City State
United States University of Colorado Anschutz Medical Campus Aurora Colorado

Sponsors (2)

Lead Sponsor Collaborator
University of Colorado, Denver National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weight Change Change in body weight (kg) Baseline to 54 months
Primary Weight Maintenance Change in body weight (kg) 18 months to 54 months
Primary Fat Mass Change Change in Fat Mass (kg) Baseline to 54 months
Primary Fat Free Mass Change Change in Fat Free Mass (kg) Baseline to 54 months
Primary Fat Mass Maintenance Change in Fat Mass (kg) 18 months to 54 months
Primary Fat Free Mass Maintenance Change in Fat Free Mass (kg) 18 months to 54 months
Secondary Change in Physical Activity Patterns Physical activity patterns as measured by SenseWear armband (min/day) 0, 6, 12, 18, 24, 54 month
Secondary Physical Activity Patterns Physical activity patterns as measured by ActivPAL, Actigraph (min/day) 54 month
Secondary Change in Sleep Sleep patterns as measured by SenseWear armband (h/day) 0, 6, 12, 18, 24, 54 month
Secondary Sleep Patterns Sleep patterns as measured by Actiwatch-2, ActivPAL, Actigraph (h/day) 54 month
Secondary Change in Energy Intake Energy Intake patterns as measured by 3 day food record (kcal/day 0, 6, 12, 18, 54 month
Secondary Energy Intake Patterns Energy Intake patterns as measured by 24 hour food recall and meallogger smartphone application (kcal/day) 54 month
Secondary Resting Metabolic Rate Resting metabolic rate as measured using indirect calorimetry (kcal/day) 54 month
Secondary Total Daily Energy Expenditure Total Daily Energy Expenditure as measured by doubly labeled water (kcal/day) 54 month
Secondary Physical Activity Energy Expenditure Physical Activity Energy Expenditure as measured by doubly labeled water (kcal/day) 54 month
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2